Illingworth's CRO Team
An Introduction to Key Members of Our Team
Illingworth Research Group appreciates a vital component in delivering projects successfully is developing a strong relationship between the sponsor and CRO. This is why we place great emphasis on attracting, training and retaining excellent industry talents, to deliver excellent service to our sponsors. As a family owned and run business, the company offers open communication with a flexible and supportive approach, meaning our CRO services are unique in that we can offer a more personal touch.
John Illingworth, Chief Executive Officer
Having gained over 30 years of experience, initially at ICI (now AstraZeneca) and then at Serono, John became a freelance Clinical Research Manager in 1996. He founded Clinical Development and Support Services Ltd (CDSS) in 1998. John spent 10 years teaching on the MSc in Clinical Research, Diploma and Certificate courses at Liverpool John Moores University and is still an honorary lecturer there. He was on the executive committee of the Association of Clinical Research in the pharmaceutical industry (now the Institute for Clinical Research) for 6 years.
Whilst gaining his Institute of Directors Diploma in company direction, John continued to oversee the steady expansion of CDSS, promoting the company both within the UK and overseas to the biotech, pharmaceutical and medical device industries and is a familiar and respected face at conferences, exhibitions and seminars all over the world.
Following the expansion of CDSS and the growth of its contract research nursing operation to become the leading independent supplier of research nurses in the UK, John oversaw the strategic realignment of the company in 2011 to become Illingworth Research Ltd and ResearchNurses.co allowing both companies to focus on their core business of clinical trial management and contract supply of Research Nurses respectively.
Dr Mike Davies, Chief Medical Officer
A high achieving Medic and Surgeon and latterly senior pharmaceutical executive whose broad experience and understanding of the clinical research environment provides an invaluable resource for the Illingworth Research team.
His significant history in both medicine and surgery facilitated his transition into pharmaceutical medicine, where he developed over ten patents for work in the discovery of wound healing, dermatology and cardiovascular compounds. Mike has provided scientific and medical expertise and leadership to a global product strategy from concept through to registration and throughout the life-cycle of important and valuable medical compounds.
Having completed clinical research in all four phases of drug development and gained extensive experience in areas of drug development and marketing, Mike now provides consultancy advice on pharmaceutical and clinical affairs.
View profile and connect on LinkedIn
Melanie Haisley, Vice President Clinical Operations
Melanie joined the company in 2000 following completion of her PhD in Cell Biology at Manchester University. She started work as a trainee Clinical Research Associate (CRA) and after working extensively in Phase I studies, moved into later phase work and then project management mainly in the field of oncology.
Melanie also progressed within the company, being promoted to CRA Team Manager in 2004 and then to Director of Clinical Operations in 2007. As a result of her experience working in a variety of clinical research settings and facilities over the years, Melanie has the ability to apply her knowledge of the clinical research industry to advise clients on their specific requirements. With her keen attention to detail and focus on customer service, Melanie ensures that Illingworth Research provides each client with the complete and careful attention that they require.
Fiona Hartig, Director of Clinical Operations
Fiona joined the company in 2014 as Clinical Operations Manager and was appointed Director of Clinical Operations in 2016. She has over 13 years’ experience working within clinical research, having worked with a variety of companies, from blue chip and smaller European Pharmaceutical companies, those concentrating on drug delivery systems, radiopharmaceuticals and Contract Research Organisations.
She has worked in phases I-IV and across a variety of therapeutic areas, including cardiovascular, diabetes, oncology, neurology, women’s health, hepatology respiratory and endocrinology studies.
Fiona has extensive experience in running clinical trials, from project management, monitoring (hospital, GP, and Phase I sites), protocol writing, CRF design, drug packaging, data management, clinical report writing and vendor management. As Director of Clinical Operations, Fiona is responsible for the management of the clinical operations team, including training and development. She is client focussed and strives to ensure the clinical team provides an excellent standard of service. She believes the key to this is effective communication and team working skills.
Yvonne joined Illingworth Research Group over 4 years’ ago. She has over 14 years’ experience in clinical research; 4 years as PM/Sen CRA, 8 years monitoring in both non-commercial and commercial settings, in Phases I to III, in therapeutic areas including chronic refractory cough, asthma, RSV, Cardiogenic Pulmonary Oedema and cardiac markers. Prior to this, she worked in general nursing.
Yvonne has experience within the pharmaceutical industry working within a Phase I unit running PK studies in both healthy volunteer and patient studies, covering a wide range of therapeutic areas. Yvonne uses her background in nursing to compliment her Project Management and Monitoring skills which allows for significant appreciation of the challenges faced when dealing with study sites. Additionally, Yvonne has extensive experience working in Emergency Medicine research, including medical device studies. She has many years working as a general nurse in Liver transplantation, general medicine, renal and respiratory care.